Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders’ Equity (Deficit) - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Deficit Cumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive Income (Loss)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance (in shares)			91,512,140
Beginning balance at Dec. 31, 2021	$ 179,106	$ 845	$ 9	$ 570,794	$ (391,656)	$ 845	$ (41)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(14,626)				(14,626)
Other comprehensive loss	(77)						(77)
Stock options exercised (in shares)			21,556
Stock options exercised	113			113
Stock-based compensation	3,548			3,548
Vested restricted stock units (in shares)			42,125
Common stock withheld for tax obligation and net settlement (in shares)			(3,611)
Common stock withheld for tax obligation and net settlement	(20)			(20)
Ending balance (in shares) at Mar. 31, 2022			91,572,210
Ending balance at Mar. 31, 2022	168,889		$ 9	574,435	(405,437)		(118)
Beginning balance at Dec. 31, 2021	179,106	845	$ 9	570,794	(391,656)	$ 845	(41)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(24,639)
Other comprehensive loss	(79)
Ending balance (in shares) at Jun. 30, 2022			92,409,276
Ending balance at Jun. 30, 2022		162,936	$ 9	578,496	(415,449)		(120)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance (in shares)			91,572,210
Beginning balance at Mar. 31, 2022	168,889		$ 9	574,435	(405,437)		(118)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(10,012)				(10,012)
Other comprehensive loss	(2)						(2)
Stock options exercised (in shares)			22,000
Stock options exercised	9			9
Stock-based compensation	3,912			3,912
Vested restricted stock units (in shares)			761,394
Shares issued under employee stock purchase plan (in shares)			58,111
Shares issued under employee stock purchase plan	157			157
Common stock withheld for tax obligation and net settlement (in shares)			(4,439)
Common stock withheld for tax obligation and net settlement	(17)			(17)
Ending balance (in shares) at Jun. 30, 2022			92,409,276
Ending balance at Jun. 30, 2022		$ 162,936	$ 9	578,496	(415,449)		(120)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance (in shares)			92,409,276
Beginning balance (in shares)			92,907,351
Beginning balance at Dec. 31, 2022	146,360		$ 9	586,213	(439,830)		(32)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(18,867)				(18,867)
Other comprehensive loss	19						19
Stock-based compensation	3,772			3,772
Vested restricted stock units (in shares)			549,484
Ending balance (in shares) at Mar. 31, 2023			93,456,835
Ending balance at Mar. 31, 2023	131,284		$ 9	589,985	(458,697)		(13)
Beginning balance at Dec. 31, 2022	146,360		$ 9	586,213	(439,830)		(32)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(32,282)
Other comprehensive loss	$ 33
Stock options exercised (in shares)	2,300
Ending balance (in shares) at Jun. 30, 2023			95,060,526
Ending balance at Jun. 30, 2023	$ 124,400		$ 9	596,504	(472,113)		0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance (in shares)			93,456,835
Beginning balance at Mar. 31, 2023	131,284		$ 9	589,985	(458,697)		(13)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(13,416)				(13,416)
Other comprehensive loss	13						13
Stock options exercised (in shares)			2,300
Stock options exercised	4			4
Stock-based compensation	6,413			6,413
Vested restricted stock units (in shares)			1,532,507
Shares issued under employee stock purchase plan (in shares)			68,884
Shares issued under employee stock purchase plan	102			102
Ending balance (in shares) at Jun. 30, 2023			95,060,526
Ending balance at Jun. 30, 2023	$ 124,400		$ 9	$ 596,504	$ (472,113)		$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance (in shares)			95,060,526